News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,223 Results
Type
Article (9217)
Company Profile (124)
Press Release (275882)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (85156)
Career Advice (269)
Deals (14677)
Drug Delivery (34)
Drug Development (26804)
Employer Resources (56)
FDA (8038)
Job Trends (7357)
News (137240)
Policy (11324)
Tag
Academia (1164)
Accelerated approval (1)
Adcomms (1)
Allergies (41)
Alliances (26434)
ALS (46)
Alzheimer's disease (609)
Antibody-drug conjugate (ADC) (77)
Approvals (8145)
Artificial intelligence (202)
Autoimmune disease (7)
Automation (14)
Bankruptcy (75)
Best Places to Work (6682)
BIOSECURE Act (10)
Biosimilars (46)
Biotechnology (79)
Bladder cancer (48)
Brain cancer (14)
Breast cancer (153)
Cancer (1286)
Cardiovascular disease (93)
Career advice (244)
Career pathing (9)
CAR-T (85)
Cell therapy (248)
Cervical cancer (15)
Clinical research (23289)
Collaboration (655)
Compensation (136)
Complete response letters (5)
COVID-19 (714)
CRISPR (23)
C-suite (187)
Cystic fibrosis (39)
Data (1327)
Denatured (13)
Depression (22)
Diabetes (125)
Diagnostics (3235)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (20)
Drug discovery (70)
Drug pricing (47)
Drug shortages (3)
Duchenne muscular dystrophy (47)
Earnings (28155)
Editorial (8)
Employer branding (4)
Employer resources (49)
Events (44122)
Executive appointments (547)
FDA (8941)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (551)
Gene editing (50)
Generative AI (15)
Gene therapy (155)
GLP-1 (221)
Government (1372)
Grass and pollen (1)
Guidances (87)
Healthcare (9089)
Huntington's disease (4)
IgA nephropathy (14)
Immunology and inflammation (42)
Indications (25)
Infectious disease (786)
Inflammatory bowel disease (70)
Inflation Reduction Act (6)
Influenza (31)
Intellectual property (65)
Interviews (38)
IPO (6228)
IRA (21)
Job creations (1056)
Job search strategy (213)
Kidney cancer (2)
Labor market (12)
Layoffs (110)
Leadership (6)
Legal (1946)
Liver cancer (33)
Lung cancer (183)
Lymphoma (79)
Machine learning (7)
Management (17)
Manufacturing (207)
MASH (23)
Medical device (8813)
Medtech (8815)
Mergers & acquisitions (8876)
Metabolic disorders (259)
Multiple sclerosis (34)
NASH (1)
Neurodegenerative disease (35)
Neuropsychiatric disorders (6)
Neuroscience (884)
NextGen: Class of 2025 (2856)
Non-profit (2315)
Now hiring (4)
Obesity (108)
Opinion (97)
Ovarian cancer (44)
Pain (56)
Pancreatic cancer (45)
Parkinson's disease (84)
Partnered (15)
Patents (145)
Patient recruitment (76)
Peanut (20)
People (26796)
Pharmaceutical (35)
Pharmacy benefit managers (2)
Phase I (6727)
Phase II (9374)
Phase III (8785)
Pipeline (698)
Policy (58)
Postmarket research (817)
Preclinical (2248)
Press Release (48)
Prostate cancer (62)
Psychedelics (4)
Radiopharmaceuticals (167)
Rare diseases (166)
Real estate (2664)
Recruiting (22)
Regulatory (9040)
Reports (20)
Research institute (1181)
Resumes & cover letters (29)
Rett syndrome (3)
RSV (10)
Schizophrenia (40)
Series A (96)
Series B (67)
Service/supplier (8)
Sickle cell disease (22)
Special edition (2)
Spinal muscular atrophy (48)
Sponsored (12)
Startups (1804)
State (1)
Stomach cancer (3)
Supply chain (35)
Tariffs (23)
The Weekly (2)
Vaccines (219)
Venture capitalists (20)
Weight loss (47)
Women's health (20)
Worklife (7)
Date
Today (100)
Last 7 days (520)
Last 30 days (1739)
Last 365 days (18271)
2025 (6859)
2024 (19237)
2023 (20345)
2022 (24908)
2021 (26069)
2020 (24843)
2019 (23593)
2018 (17765)
2017 (15417)
2016 (14344)
2015 (15803)
2014 (11045)
2013 (8923)
2012 (9625)
2011 (9360)
2010 (7837)
Location
Africa (238)
Alabama (25)
Alaska (4)
Arizona (81)
Arkansas (11)
Asia (19611)
Australia (2393)
California (2954)
Canada (1126)
China (448)
Colorado (152)
Connecticut (180)
Delaware (95)
Europe (44760)
Florida (545)
Georgia (134)
Idaho (23)
Illinois (352)
India (16)
Indiana (231)
Iowa (9)
Japan (120)
Kansas (52)
Kentucky (9)
Louisiana (5)
Maine (27)
Maryland (474)
Massachusetts (2322)
Michigan (126)
Minnesota (235)
Mississippi (1)
Missouri (62)
Montana (23)
Nebraska (12)
Nevada (47)
New Hampshire (44)
New Jersey (1130)
New Mexico (19)
New York (1000)
North Carolina (575)
North Dakota (7)
Northern California (1194)
Ohio (125)
Oklahoma (11)
Oregon (20)
Pennsylvania (771)
Puerto Rico (5)
Rhode Island (23)
South America (363)
South Carolina (22)
South Dakota (1)
Southern California (1111)
Tennessee (79)
Texas (489)
United States (12590)
Utah (96)
Virginia (87)
Washington D.C. (36)
Washington State (245)
West Virginia (1)
Wisconsin (58)
285,223 Results for "shangpharma innovation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Low-Price Drug Nations Catching ‘Free Ride’ on US Innovation, Report Says
No Patient Left Behind says that drug value assessments used in countries like Canada and Germany undervalue innovative medicines by 90% and mislead U.S. policymakers into thinking Americans are overpaying.
May 2, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
PlasCred Circular Innovations Inc. Announces Alberta Innovates Funding Grant
April 8, 2025
·
6 min read
Radiopharmaceuticals
Radiopharma Powerhouses Push Frontiers With New Indications, Innovation
At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a radiopharmaceuticals market that could top $16 billion by 2033.
May 12, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Lumendi Completes Strategic Restructuring to Accelerate Growth and Innovation
May 2, 2025
·
2 min read
Press Releases
GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy
January 23, 2025
·
2 min read
Press Releases
BostonGene Named a Fierce Life Sciences Innovation Awards Winner in the AI Innovation Category
March 13, 2025
·
4 min read
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
·
6 min read
·
Thomas M. Kaiser
Press Releases
Innovent Announces 2024 Annual Results and Business Updates
March 27, 2025
·
8 min read
Cell therapy
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
January 8, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
1 of 28,523
Next
